Exercise Limitation 3 Months Post Severe COVID-19 Lung Infection
How often do survivors of severe COVID-19 pulmonary infection experience long-term exercise capacity limitation, and what factors are associated with this condition?
COVID19
Adverse Effects Generally Mild After BNT162b2 mRNA Booster in Over 60s
Adverse effects (AEs) after the booster BNT162b2 mRNA vaccine dose are generally mild and similar to those reported after the second dose.
Living Guideline Updated for Drug Treatment of COVID-19
In the living guideline developed by the World Health Organization and published in The BMJ, recommendations on drug options for the treatment of COVID-19 have been updated.
Biden Administration Extends COVID-19 Public Health Emergency for 90 Days
America’s public health emergency plan for COVID-19 will continue for at least another 90 days, the Biden administration announced Wednesday.
Gut Microbiota Affect Immune Response, Adverse Effects From COVID-19 Vaccination
Researchers assessed the composition of gut microbiota in relation to an immune response to COVID-19 vaccines and vaccine-associated adverse events.
Subcutaneous mAb May Benefit High-Risk Outpatients With COVID-19
For high-risk outpatients with mild-to-moderate COVID-19, subcutaneously administered monoclonal antibody (mAb) treatment with casirivimab and imdevimab is associated with reduced risk for 28-day hospitalization or death compared with no mAb treatment.
Patient-Dependent Factors and Decreased PA Pressure Monitoring During the COVID-19 Pandemic
A study examining hemodynamically guided management of patients with chronic HF found significant changes in clinical outcomes during the COVID-19 pandemic.
Pfizer, BioNTech Plan to Request EUA Based on Booster Data in 5 to 11 Year-Olds
Data from a subanalysis of 30 sera demonstrated that following a third dose, a 36-fold increase in SARS-CoV-2 Omicron neutralizing antibody titers was observed in this age group.
Incidence of Shingles Up for Patients Aged 50 and Older With Past COVID-19 Diagnosis
For adults aged 50 years or older, those with a COVID-19 diagnosis have an increased risk for developing herpes zoster.
Biden Makes National Push for ‘Long COVID’ Research
President Joe Biden on Tuesday ordered a new national push to research the nature and impact of “long COVID,” a constellation of sometimes debilitating symptoms that linger long after infection in nearly one-third of Americans.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...